HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Clinical trials for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to tame HPV throat cancer with fewer side effects
Disease control Not yet recruitingThis early-phase trial tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation to the neck can safely and effectively treat early-stage HPV-positive throat cancer before surgery. About 35 participants will take the drug daily for 10 days and receive …
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: John Lukens • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Symptom relief Not yet recruitingThis study is for people with HPV-related oropharyngeal (throat) cancer, which often responds well to treatment. The goal is to see if lowering the radiation dose to certain areas can reduce side effects like dry mouth without hurting the chance of curing the cancer. About 132 pa…
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC